LV11042B - METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole - Google Patents

METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole Download PDF

Info

Publication number
LV11042B
LV11042B LVP-93-462A LV930462A LV11042B LV 11042 B LV11042 B LV 11042B LV 930462 A LV930462 A LV 930462A LV 11042 B LV11042 B LV 11042B
Authority
LV
Latvia
Prior art keywords
zellen
die
von
der
fusion
Prior art date
Application number
LVP-93-462A
Other languages
English (en)
Latvian (lv)
Other versions
LV11042A (lv
Inventor
Herbert Jungfer
Heinrich Barchet
Winfried Albert
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of LV11042A publication Critical patent/LV11042A/xx
Publication of LV11042B publication Critical patent/LV11042B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
LVP-93-462A 1982-05-04 1993-06-02 METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole LV11042B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3216650 1982-05-04
DE19823245665 DE3245665A1 (de) 1982-05-04 1982-12-09 Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung

Publications (2)

Publication Number Publication Date
LV11042A LV11042A (lv) 1996-02-20
LV11042B true LV11042B (en) 1996-06-20

Family

ID=25801552

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-462A LV11042B (en) 1982-05-04 1993-06-02 METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole

Country Status (18)

Country Link
US (1) US5114847A (ja)
EP (1) EP0093436B1 (ja)
JP (1) JPH0753110B2 (ja)
AU (1) AU538828B2 (ja)
CA (1) CA1201396A (ja)
DD (1) DD210708A5 (ja)
DE (2) DE3245665A1 (ja)
DK (1) DK199083A (ja)
ES (1) ES522086A0 (ja)
FI (1) FI85282C (ja)
GR (1) GR78532B (ja)
HU (1) HU196456B (ja)
IE (1) IE54881B1 (ja)
IL (1) IL68515A (ja)
LV (1) LV11042B (ja)
PT (1) PT76629B (ja)
SU (1) SU1424744A3 (ja)
YU (1) YU94883A (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70686A (en) * 1983-01-20 1988-07-31 Suntory Ltd Mutant tumor cell lines for use in the preparation of hybridomas and the hybridomas obtained therefrom
DE3342736A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Hybridoma-antikoerper
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide
DE3420926A1 (de) * 1984-06-05 1985-12-05 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur differenzierten bestimmung von isoenzymen der alkalischen phosphatase sowie hierzu geeigneter monoklonaler antikoerper
FR2581393B2 (fr) * 1985-05-02 1989-07-21 Grp Genie Genetique Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit
JPS63500001A (ja) * 1985-06-11 1988-01-07 ジ・アップジョン・カンパニ− ニンジンにおける雄性不稔性の移入
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
EP0239102A3 (en) * 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
DE3627326A1 (de) * 1986-08-12 1988-02-18 Boehringer Mannheim Gmbh Immortalisierung durch dns-uebertragung
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US5175004A (en) * 1988-12-27 1992-12-29 Matsumura Kenneth N Propagatable, new combinant cells for cellular replacement therapy
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5358844A (en) * 1993-02-18 1994-10-25 Brigham And Women's Hospital, Inc. Preservation of blood platelets
JP3096737B1 (ja) * 1999-07-19 2000-10-10 工業技術院長 ヒト・動物細胞培養液
WO2023069575A1 (en) * 2021-10-21 2023-04-27 Parow Entheobiosciences Llc Method for producing 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in vitro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594097A (en) * 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
US4465769A (en) * 1981-12-11 1984-08-14 The United States Of America As Represented By The Department Of Health And Human Services Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes

Also Published As

Publication number Publication date
JPH0753110B2 (ja) 1995-06-07
SU1424744A3 (ru) 1988-09-15
IL68515A (en) 1988-11-15
DE3245665A1 (de) 1983-11-10
ES8402346A1 (es) 1984-02-01
US5114847A (en) 1992-05-19
FI831509A0 (fi) 1983-05-03
HU196456B (en) 1988-11-28
IE830945L (en) 1983-11-04
DD210708A5 (de) 1984-06-20
FI85282C (fi) 1992-03-25
FI85282B (fi) 1991-12-13
EP0093436A3 (en) 1984-05-02
GR78532B (ja) 1984-09-27
IE54881B1 (en) 1990-03-14
PT76629B (de) 1985-12-03
AU1414183A (en) 1983-11-10
CA1201396A (en) 1986-03-04
AU538828B2 (en) 1984-08-30
DK199083D0 (da) 1983-05-04
YU94883A (en) 1988-10-31
EP0093436A2 (de) 1983-11-09
JPS61205486A (ja) 1986-09-11
DE3367412D1 (en) 1986-12-11
PT76629A (de) 1983-06-01
DK199083A (da) 1983-11-05
ES522086A0 (es) 1984-02-01
EP0093436B1 (de) 1986-11-05
IL68515A0 (en) 1983-07-31
FI831509L (fi) 1983-11-05
LV11042A (lv) 1996-02-20

Similar Documents

Publication Publication Date Title
LV11042B (en) METHOD FOR PRODUCING OF PERMANENT ANIMAL AND HUMAN CELL LINES AND USE THEREOFL ACARICIDALLY ACTIVE TETRAZINE DERIVATIVESrylpirrole
EP0260610B1 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE3301249C2 (ja)
DE2840039C2 (ja)
DE3588177T2 (de) Verfahren zur Feststellung der Anwesenheit eines selbstimmunen Antikörpers
DE68913402T2 (de) Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.
DD204849A5 (de) Verfahren zur herstellung von produkten fuer die behandlung von melanomen
DE69628298T2 (de) Immunovektoren zum transport in die zelle und den zellkern
CH683526A5 (de) Zellinie für die Herstellung von Antikörper bildenden Hybridomen, Verfahren zur Herstellung einer menschlichen Zellinie und Antikörper produzierendes Hybridom.
DE69033457T2 (de) Prohormonspaltungsplatzblockierungsantikörper
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
EP0195331B1 (de) Monoklonale Antikörper gegen atriale, natriurethische Peptide
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE3413339A1 (de) Gegen pilze der gattung candida gerichtete antikoerper
DE19915057A1 (de) Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3786173T2 (de) Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten.
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DE3239863A1 (de) Verfahren zur herstellung von subkultivierbaren lymphokin-bildenden human-t-zellenhybridomas
DE3211356A1 (de) Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
EP0365818B1 (de) Immunologischer Nachweis von Atrazin und Atrazinderivaten
AT396936B (de) Hybridoma zell-linien und verfahren zu ihrer herstellung sowie die verwendung der genannten zell-linien zur herstellung von monoklonalen antikörpern
DE3854740T2 (de) Menschlicher monoklonaler antikörper gegen candida.
DE19962583A1 (de) Antikörper gegen Plasmazellen
DE68913872T2 (de) Monoklonale Antikörper gegen den menschlichen Epidermal-Wachstumsfaktor mit hohem Molekulargewicht.
DE68913793T2 (de) Ein von einem Human-Human-Hybridom abgeleiteter monoklonaler Antikörper und dessen Verwendung.